We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences recruiting specialist Coulter Partners has placed Anna Wasyl as the new CFO of Tristel plc. “Anna’s appointment comes at an exciting and important time for Tristel,” said Matt Sassone, CEO of Tristel. “Her broad international background, commercial mindset, and hands-on approach to both strategy and execution are exactly what we need as we enter
Life sciences recruiting specialist Coulter Partners has recruited Steven Sciuto as the new CFO of iOnctura. “Following our successful initiation of a number of Phase II studies for our lead asset, roginolisib, we are committed to building a world-class leadership team that not only delivers on the promise of this asset but also strengthens our entire portfolio,” said Catherine
Life sciences recruiting specialist Coulter Partners has placed Frederick Westhorpe as chief scientific officer of Biomia. “We are excited to welcome Frederick to Biomia, and confident that his extensive small molecule drug discovery and development expertise will complement the team and guide our company’s next phase of strategic growth,” said Michael Krogh Jensen, Biomia’s co-founder and CEO.
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Stuart Hughes as CEO of Nuage Therapeutics. “Coulter Partners has been an invaluable partner in this crucial appointment for Nuage Therapeutics,” said Vanessa Malier, chair of the board of directors of Nuage Therapeutics. “Their team demonstrated exceptional dedication and a truly collaborative spirit, working closely
Coulter Partners successfully led a search for Evondos Group and is pleased to announce the placement of Tom Ellison as Chief Financial Officer (CFO). Evondos Group is the leading provider of automated medicine dispensing services in northern Europe. Their solutions ensure safe and timely medication for home care clients, improving patient safety, treatment outcomes and quality
Coulter Partners successfully led the search for Hans T. Schambye, MD, PhD for his appointment to the Board of Directors at BOOST Pharma (“BOOST”), and is now pleased to announce his transition to Chief Executive Officer (CEO). BOOST Pharma is a clinical‑stage biopharmaceutical company developing novel, first‑in‑class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases.
Coulter Partners successfully led a search assignment for Concept Life Sciences and is pleased to announce the placement of Dr. Adam Davenport as Chief Scientific Officer (CSO). Concept Life Sciences is a leading global contract research organization (CRO) specializing in integrated drug discovery, development, and analytical services. The company provides consultative and collaborative solutions that enable
Kaffe Bueno is a Danish bioscience company and certified B Corp that upcycles coffee by-products into high-performance, active, and functional ingredients. Using green chemistry and biotechnology, the company unlocks the full potential of coffee by-products to provide sustainable, natural solutions for the personal care, nutraceutical, food, and industrial sectors. As CEO, Thomas will lead Kaffe Bueno
Coulter Partners successfully led a search assignment for TreeFrog Therapeutics and is pleased to announce the placement of Mark Rothera as Chief Executive Officer (CEO). TreeFrog Therapeutics is a French regenerative medicine biotech focused on providing mass access to cell therapies. By combining biophysics and engineering, they produce high-quality cells at unprecedented scale and cost-effectiveness through internal programs and strategic
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024